Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders
January 16, 2025 03:00 ET | Source: Actimed Therapeutics Fabio Dorigotti brings…
Actimed Therapeutics Announces Publication of Successful S-pindolol benzoate (ACM-001.1) Phase 1 Study in The Journal of Cachexia, Sarcopenia and Muscle
December 13, 2024 03:00 ET | Source: Actimed Therapeutics London, UK –…